Sonya J Snedecor
Biographic Data
| ID | 5413291 |
|---|---|
| NAME | Sonya J Snedecor |
| GIVEN NAMES | Sonya J |
| FAMILY NAME | Snedecor |
| SIGNATURE | SNEDECOR S J |
| AFFILIATIONS | Pharmerit (United States) |
| ORCID | 0000-0002-0206-8522 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2020 |
| LATEST PUBLICATION YEAR | 2021 |
| H-INDEX | 0 |
Economic Value of Lost Productivity Attributable to Human Papillomavirus Cancer Mortality in the United States
Objectives: To estimate years of potential life lost (YPLL) and present value of future lost productivity (PVFLP) associated with premature mortality due to HPV-attributable cancers, specifically those targeted by nonavalent HPV (9vHPV) vaccination, in the United States (US) before vaccine use. Methods: YPLL was estimated from the reported number of deaths in 2017 due to HPV-related cancers, the proportion attributable to 9vHPV-targeted types, an…
Cost-effectiveness of alternative strategies for vaccination of adolescents against serogroup B IMD with the MenB-FHbp vaccine in Canada
Our model indicated that if the vaccine reduces risk of carriage acquisition, vaccination of older adolescents, even at lower uptake, could have a significant public health impact. Due to low disease incidence, MnB vaccination is unlikely to meet widely accepted cost-effectiveness thresholds, but evaluations of new programs should consider the overall benefits of the vaccination
No prominent works on this page.
Cost-effectiveness of alternative strategies for vaccination of adolescents against serogroup B IMD with the MenB-FHbp vaccine in Canada
Our model indicated that if the vaccine reduces risk of carriage acquisition, vaccination of older adolescents, even at lower uptake, could have a significant public health impact. Due to low disease incidence, MnB vaccination is unlikely to meet widely accepted cost-effectiveness thresholds, but evaluations of new programs should consider the overall benefits of the vaccination
Economic Value of Lost Productivity Attributable to Human Papillomavirus Cancer Mortality in the United States
Objectives: To estimate years of potential life lost (YPLL) and present value of future lost productivity (PVFLP) associated with premature mortality due to HPV-attributable cancers, specifically those targeted by nonavalent HPV (9vHPV) vaccination, in the United States (US) before vaccine use. Methods: YPLL was estimated from the reported number of deaths in 2017 due to HPV-related cancers, the proportion attributable to 9vHPV-targeted types, an…
Demography (2 works) · Environmental health (2 works) · Medicine (2 works) · Population (2 works) · Attributable risk (1 work) · Bacterial Infections and Vaccines (1 work) · Carriage (1 work) · Colorectal Cancer Screening and Detection (1 work) · Cost effectiveness (1 work) · Demography (1 work)